mounjaro tirzepatide news https://t.co/QYMeNhMdZk Lilly's (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease Use of the dual GIP/GLP-1

Lower Overhead Structure Telehealth platforms operate with lower overhead than traditional pharmaceutical companies: no physical clinic locations to maintain, providers work remotely reducing facility costs, streamlined administrative processes through technology, and efficient inventory management

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight (TRIUMPH)

No cravings and I am honestly not hungry

Do not use in combination with other GLP-1 receptor agonists or GIP/GLP-1 receptor agonists

BTX-A inhibits the release of calcitonin gene-related peptide (CGRP), an inflammatory neuropeptide

10.1016/j.toxicon.2020.09.014 56 De SouzaR